SONIRE’s HIFU Therapy System Designated as Breakthrough Device by FDA

Posted on by

TOKYO, Oct. 16, 2024 /PRNewswire/ — SONIRE Therapeutics Inc. (hereinafter referred to as “SONIRE”), based in Tokyo, Japan, announces that its self-developed next-generation HIFU (High-Intensity Focused Ultrasound) therapy system (development code: Suizenji) has been designated as a…